3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Terminated
1
Recruiting
1
Completed
1
Active not recruiting
1
Sponsor Class
OTHER_GOV
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Conditions
Colorectal Neoplasms
3
Breast Neoplasms
3
Stomach Neoplasms
2
Pancreatic Neoplasms
2
Multiple Myeloma
2
Carcinoma, Non-Small-Cell Lung
2
Tongue Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Recurrence
1
Prostatic Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pancreatic Tubular Adenocarcinoma
1
Neoplasms
1
Neoplasm Metastasis
1
Lymphoma, Large B-Cell, Diffuse
1
Infections
1
Hemangioma, Cavernous, Central Nervous System
1
Hemangioma
1
Head and Neck Neoplasms
1
Gallbladder Neoplasms
1
Gallbladder Cancer Unresectable
1
Fallopian Tube Neoplasms
1
Endometrial Neoplasms
1
Colonic Neoplasms
1
Cholangiocarcinoma
1
Cancer-Related Condition
1
Cachexia
1
Brenner Tumor
1
Biliary Tract Neoplasms
1
Arthritis, Rheumatoid
1
Interventions
Cisplatin
28
Radiotherapy
19
pembrolizumab
9
Paclitaxel
9
Surveys and Questionnaires
8
Cetuximab
8
Fluorouracil
7
Docetaxel
7
Radiotherapy, Intensity-Modulated
6
Carboplatin
6
apatinib
5
Low-Level Light Therapy
5
durvalumab
4
Standard of Care
4
Magnetic Resonance Imaging
4
Gemcitabine
4
Cyclophosphamide
4
Celecoxib
4
Blood Specimen Collection
4
Tegafur
3
Radiation
3
Oncolytic Virotherapy
3
Nivolumab
3
Magnetic Resonance Spectroscopy
3
Lidocaine
3
Immunoenzyme Techniques
3
Drug Therapy
3
Chemotherapy, Adjuvant
3
Biopsy
3
toripalimab
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Head and Neck Neoplasms
×
Observation
×
Clear all
NCT02748707
2022-04-28
ERLO-XIB
Tata Memorial Hospital
Phase 2
Unknown
64 enrolled